Geneos Wealth Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.4K | Sell |
108
-50
| -32% | -$1.58K | ﹤0.01% | 2677 |
|
2025
Q1 | $5.18K | Buy |
158
+129
| +445% | +$4.23K | ﹤0.01% | 2744 |
|
2024
Q4 | $1.05K | Buy |
29
+9
| +45% | +$326 | ﹤0.01% | 2757 |
|
2024
Q3 | $624 | Buy |
+20
| New | +$624 | ﹤0.01% | 2520 |
|
2022
Q3 | – | Sell |
-170
| Closed | -$4K | – | 2529 |
|
2022
Q2 | $4K | Sell |
170
-5
| -3% | -$118 | ﹤0.01% | 2277 |
|
2022
Q1 | $5K | Buy |
175
+5
| +3% | +$143 | ﹤0.01% | 2358 |
|
2021
Q4 | $4K | Hold |
170
| – | – | ﹤0.01% | 2486 |
|
2021
Q3 | $4K | Hold |
170
| – | – | ﹤0.01% | 2532 |
|
2021
Q2 | $5K | Hold |
170
| – | – | ﹤0.01% | 2462 |
|
2021
Q1 | $5K | Hold |
170
| – | – | ﹤0.01% | 2674 |
|
2020
Q4 | $4K | Hold |
170
| – | – | ﹤0.01% | 2562 |
|
2020
Q3 | $3K | Hold |
170
| – | – | ﹤0.01% | 2340 |
|
2020
Q2 | $3K | Hold |
170
| – | – | ﹤0.01% | 2302 |
|
2020
Q1 | $2K | Hold |
170
| – | – | ﹤0.01% | 2297 |
|
2019
Q4 | $4K | Hold |
170
| – | – | ﹤0.01% | 2260 |
|
2019
Q3 | $4K | Hold |
170
| – | – | ﹤0.01% | 2179 |
|
2019
Q2 | $5K | Hold |
170
| – | – | ﹤0.01% | 2129 |
|
2019
Q1 | $5K | Hold |
170
| – | – | ﹤0.01% | 2059 |
|
2018
Q4 | $5K | Hold |
170
| – | – | ﹤0.01% | 2004 |
|
2018
Q3 | $8K | Hold |
170
| – | – | ﹤0.01% | 1934 |
|
2018
Q2 | $10K | Hold |
170
| – | – | ﹤0.01% | 1734 |
|
2018
Q1 | $7K | Sell |
170
-117
| -41% | -$4.82K | ﹤0.01% | 1782 |
|
2017
Q4 | $11K | Hold |
287
| – | – | ﹤0.01% | 1616 |
|
2017
Q3 | $11K | Sell |
287
-1,644
| -85% | -$63K | ﹤0.01% | 1552 |
|
2017
Q2 | $83K | Buy |
1,931
+969
| +101% | +$41.7K | 0.01% | 740 |
|
2017
Q1 | $30K | Buy |
962
+635
| +194% | +$19.8K | ﹤0.01% | 1091 |
|
2016
Q4 | $8K | Buy |
327
+40
| +14% | +$979 | ﹤0.01% | 1514 |
|
2016
Q3 | $7K | Buy |
287
+117
| +69% | +$2.85K | ﹤0.01% | 1494 |
|
2016
Q2 | $3K | Hold |
170
| – | – | ﹤0.01% | 1633 |
|
2016
Q1 | $2K | Buy |
+170
| New | +$2K | ﹤0.01% | 1689 |
|